Testosterone Replacement Therapy as a Potential Strategy to Preserve Lean Mass in Men With Persistently Low Serum Testosterone Receiving GLP-1 Receptor Agonists: A Narrative Review.

Plain-language summary

This is a narrative review (an expert summary of existing research, not a new experiment) asking whether testosterone replacement therapy (TRT) could help men with low testosterone hold onto muscle while losing weight on GLP-1 drugs (like semaglutide, used for obesity and type 2 diabetes, whose weight loss includes some muscle). The authors reviewed what is known about how these drugs affect body composition and how testosterone supports muscle, but found no trials that actually tested the two together. So their view that TRT might protect muscle here is a reasoned hypothesis, not something this review demonstrated.

Key findings

• GLP-1 RAs cause weight loss but also reduce lean mass.
• Men with low testosterone, common in obesity, may be more vulnerable to muscle loss during weight loss.
• TRT increases lean mass in men with low testosterone, but no studies have tested its effect combined with GLP-1 RAs.
• The review suggests checking testosterone levels in men on GLP-1 RAs but does not recommend routine combined therapy.